Advertisement
Advertisement
U.S. markets open in 1 hour 9 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Leap Therapeutics, Inc. (LPTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.9234-0.0533 (-5.46%)
At close: 04:00PM EDT
0.9400 +0.02 (+1.80%)
After hours: 07:18PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • D
    Davebiotech
    Headed under $1.
  • D
    Davebiotech
    Nice data coming at ESMO mid sept. 11.3mo PFS w/ combo DKK1 and Tis in 1st line GEA exceeds SOC. ORR 68%. WAKING study also good data.
    Bullish
  • K
    Know One Knows
    WTH??? Down 16% in the first hour alone!!! What's going on? We did not buy this stock just to lose a buttload of money!
  • S
    Submarine
    This is only the beginning... $LPTX
    Bullish
  • V
    Vonda
    This stock is being controlled by something or someone other than news or the market!
  • V
    ValuFin
    Nothing changed in the data today, it is still as excellent as always and Beigen’s chance to pay up for
    Licensing is still high.
    Bullish
  • J
    Junior Theurg
    Today, RAYMOND JAMES 💫 investment group, represented by 4-star analyst, biotechnology manager in the New York office, mr. Steven Seedhouse, Ph.D., has re-covered Leap Therapeutics with a target price of $3.5, up from $3 previously. The rating of $3.5 was provided under "Outperform" in an internal note to clients. Piper Sandler, analyst Joseph Catanzaro covers up to $5. Mizuho Securities analyst Mara Goldstein covers up to $6.00
    Bullish
  • S
    SD
    Something stinks here.
    Would it surprise anyone that a potential "suitor" hired a firm to drive up the price in the short term and then dump it in an effort to clean out some weak retail investors? This tactic has occurred a million times before.

    I do not own a crystal ball but.... weird. You can get the company on the cheap at present.

    GLTA
  • D
    David
    ESMO Date Mon, 12.09.2022 Found 2 Presentations For Request "DKN-01"
    https://cslide.ctimeetingtech.com/esmo2022/attendee/confcal_2/presentation/list?q=DKN-01
    e-Posters - ESMO Congress 2022
    cslide.ctimeetingtech.com
    Bullish
  • J
    Junior Theurg
    Form S-8 offers as part of an employee benefit plan.
    "EXPLANATORY NOTE"
    The stockholders of Leap Therapeutics, Inc. (the “Registrant”) approved the Leap Therapeutics, Inc. 2022 Equity Incentive Plan (the “2022 Plan”) on June 16, 2022 (the “Effective Date”). As provided in the 2022 Plan, 7,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), are available for issuance thereunder (the “New Shares”).
  • J
    Jopa
    Needs to go up 40% now to get back above where it was last week. Absolutely suck. To go from a promising stock to a piece of S literally overnight.
  • V
    Ver
    So during market 10 down, after market 12 up!!!!! How that cheese happens
  • d
    danielmaze66
    I'm at the point of just closing my eyes and holding on tight. any thoughts on what "rock bottom" looks like for LPTX?
  • V
    Vonda
    10 steps forward, 9 1/2 steps backwards!
  • S
    SD
    Keep running baby.
    Loving it. GLTA
    About time.
    Bullish
  • J
    Junior Theurg
    Incredible! Click on the embedded Clinical Trial link in the article!
    Bullish
  • V
    ValuFin
    Their expansion into huge markets is great news. It should increase their potential and stock price. Cash runway is beyond a year while Beigen will be pitching in a ton of additional cash soon.
    Bullish
Advertisement
Advertisement